Heron Therapeutics (HRTX) Current Ratio: History & Chart

Heron Therapeutics, Inc.(HRTX)

Biotechnology · Cary, NC

$0.34-0.03 (-8.43%)

Delayed quote: Oct 6, 2026, 11:35 AM EDT

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements. The company leverages its proprietary Biochronomer drug delivery platform, an advanced system that enables the controlled release of various short-acting pharmacological agents. This technology ensures therapeutic concentrations are maintained for periods ranging from days to weeks following just a single administration. Among its commercialized products is SUSTOL (granisetron), an extended-release injectable designed to prevent both immediate and delayed nausea and vomiting triggered by moderately emetogenic chemotherapy, or specific anthracycline and cyclophosphamide combination therapies. Additionally, Heron markets CINVANTI, an intravenous formulation of aprepitant. CINVANTI, which acts as a substance P/neurokinin-1 receptor antagonist, is indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients undergoing highly or moderately emetogenic cancer chemotherapy. The company's development pipeline includes ZYNRELEF, an innovative dual-acting local anesthetic that combines bupivacaine, a local anesthetic, with a low dose of the nonsteroidal anti-inflammatory drug (NSAID) meloxicam in a single fixed-dose formulation. Also in development is HTX-019, an experimental therapy aimed at preventing postoperative nausea and vomiting (PONV). Furthermore, HTX-034 is being advanced for postoperative pain management and is currently undergoing Phase Ib/II clinical trials, notably in patients recovering from bunionectomy procedures. Originally established in 1983 as A.P. Pharma, Inc., the company adopted its current name, Heron Therapeutics, Inc., in January 2014. Its corporate headquarters are situated in San Diego, California.

Cary, NC

128 employees

www.herontx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Craig Alexander Collard

View full financials

HRTX Current Ratio Metrics

CURRENT RATIO

2.49

CURRENT RATIO AVG TTM

2.17

CURRENT RATIO AVG 3Y

2.43

CURRENT RATIO AVG 5Y

2.42

CURRENT RATIO AVG 10Y

3.03

CURRENT RATIO AVG 15Y

4.01

CURRENT RATIO AVG 20Y

3.95

CURRENT VS TTM AVG

+14.69%

CURRENT VS 3Y AVG

+2.85%

CURRENT VS 5Y AVG

+3.26%

CURRENT VS 10Y AVG

-17.67%

CURRENT VS 15Y AVG

-37.84%

CURRENT VS 20Y AVG

-36.79%

SECTOR MEDIAN · HEALTHCARE

3.48

median of 699 covered companies

CURRENT VS SECTOR MEDIAN

-28.32%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
Heron Therapeutics, Inc. (HRTX)	$64.13M	2.49	2.17	2.43	2.42
Pliant Therapeutics, Inc. (PLRX)vs ›	$63.78M	9.90	11.46	13.71	15.39
Kalaris Therapeutics Inc (KLRS)vs ›	$63.26M	10.98	17.43	9.10	12.08
Alps Group Inc (ALPS)vs ›	$63.23M	0.36	0.31	0.29	1.05
InterCure Ltd. (INCR)vs ›	$63.14M	1.48	1.60	1.69	1.84
Cingulate Inc. (CING)vs ›	$66.02M	3.50	1.85	1.22	3.58
Gossamer Bio, Inc. (GOSS)vs ›	$66.42M	0.53	4.76	5.20	7.10
Adicet Bio, Inc. (ACET)vs ›	$61.23M	6.71	8.38	9.61	10.03
PDS Biotechnology Corporation (PDSB)vs ›	$60.49M	0.57	2.81	4.44	7.47
Connect Biopharma Holdings Limited (CNTB)vs ›	$60.32M	2.37	7.60	7.51	12.19

NAME

MARKET CAP

CURRENT RATIO

TTM

Heron Therapeutics, Inc. (HRTX)

$64.13M

2.49

2.17

2.43

2.42

Pliant Therapeutics, Inc. (PLRX)vs ›

$63.78M

9.90

11.46

13.71

15.39

Kalaris Therapeutics Inc (KLRS)vs ›

$63.26M

10.98

17.43

9.10

12.08

Alps Group Inc (ALPS)vs ›

$63.23M

0.36

0.31

0.29

1.05

InterCure Ltd. (INCR)vs ›

$63.14M

1.48

1.60

1.69

1.84

Cingulate Inc. (CING)vs ›

$66.02M

3.50

1.85

1.22

3.58

Gossamer Bio, Inc. (GOSS)vs ›

$66.42M

0.53

4.76

5.20

7.10

Adicet Bio, Inc. (ACET)vs ›

$61.23M

6.71

8.38

9.61

10.03

PDS Biotechnology Corporation (PDSB)vs ›

$60.49M

0.57

2.81

4.44

7.47

Connect Biopharma Holdings Limited (CNTB)vs ›

$60.32M

2.37

7.60

7.51

12.19

Current Ratio FAQ

What is the current ratio for Heron Therapeutics, Inc. (HRTX)?

The current ratio for HRTX stock is 2.49.

Is Heron Therapeutics, Inc.'s current ratio high or low?

The current ratio of 2.49 is in line with its 5-year average of 2.42, around the middle of its 5-year range (0.82–4.47).

What is the TTM average current ratio for Heron Therapeutics, Inc. (HRTX)?

The TTM average current ratio for HRTX stock is 2.17.

What is the 3Y average current ratio for Heron Therapeutics, Inc. (HRTX)?

The 3Y average current ratio for HRTX stock is 2.43.

What is the 5Y average current ratio for Heron Therapeutics, Inc. (HRTX)?

The 5Y average current ratio for HRTX stock is 2.42.

What is the 10Y average current ratio for Heron Therapeutics, Inc. (HRTX)?

The 10Y average current ratio for HRTX stock is 3.03.

What is the 15Y average current ratio for Heron Therapeutics, Inc. (HRTX)?

The 15Y average current ratio for HRTX stock is 4.01.

What is the 20Y average current ratio for Heron Therapeutics, Inc. (HRTX)?

The 20Y average current ratio for HRTX stock is 3.95.

DATE	CURRENT RATIO
2026-06-30	2.49
2026-03-31	2.53
2025-12-31	2.48
2025-09-30	2.56
2025-06-30	0.82
2025-03-31	2.40
2024-12-31	2.29
2024-09-30	2.28
2024-06-30	2.38
2024-03-31	2.47
2023-12-31	2.37
2023-09-30	2.43
2023-06-30	1.91
2023-03-31	2.29
2022-12-31	2.49
2022-09-30	2.38
2022-06-30	1.77
2022-03-31	2.39
2021-12-31	3.58
2021-09-30	4.36
2021-06-30	4.47
2021-03-31	2.70
2020-12-31	3.07
2020-09-30	3.60
2020-06-30	4.24
2020-03-31	4.53
2019-12-31	4.95
2019-09-30	3.76
2019-06-30	4.01
2019-03-31	4.40
2018-12-31	4.86
2018-09-30	7.18
2018-06-30	6.39
2018-03-31	1.94
2017-12-31	2.21
2017-09-30	2.12
2017-06-30	2.82
2017-03-31	4.91
2016-12-31	1.60
2016-09-30	3.04
2016-06-30	2.91
2016-03-31	5.64
2015-12-31	6.83
2015-09-30	9.42
2015-06-30	10.45
2015-03-31	4.86
2014-12-31	5.41
2014-09-30	7.92
2014-06-30	9.78
2014-03-31	8.09
2013-12-31	10.43
2013-09-30	4.25
2013-06-30	3.67
2013-03-31	6.08
2012-12-31	13.02
2012-09-30	14.23
2012-06-30	4.17
2012-03-31	4.09
2011-12-31	4.94
2011-09-30	8.39
2011-06-30	6.81
2011-03-31	0.89
2010-12-31	1.60
2010-09-30	2.65
2010-06-30	2.42
2010-03-31	4.15
2009-12-31	4.41
2009-09-30	0.96
2009-06-30	1.65
2009-03-31	2.80
2008-12-31	3.39
2008-09-30	2.97
2008-06-30	4.33
2008-03-31	5.15
2007-12-31	5.77
2007-09-30	11.46
2007-06-30	12.90
2007-03-31	2.68
2006-12-31	3.87
2006-09-30	7.81
2006-06-30	9.71
2006-03-31	12.00
2005-12-31	2.77
2005-09-30	3.92
2005-06-30	4.77
2005-03-31	6.91
2004-12-31	5.42
2004-09-30	7.54
2004-06-30	10.04
2004-03-31	3.82
2003-12-31	5.95
2003-09-30	6.29
2003-06-30	6.46
2003-03-31	6.64
2002-12-31	8.01
2002-09-30	6.78

DATE

CURRENT RATIO

2026-06-30

2.49

2026-03-31

2.53

2025-12-31

2.48

2025-09-30

2.56

2025-06-30

0.82

2025-03-31

2.40

2024-12-31

2.29

2024-09-30

2.28

2024-06-30

2.38

2024-03-31

2.47

2023-12-31

2.37

2023-09-30

2.43

2023-06-30

1.91

2023-03-31

2.29

2022-12-31

2.49

2022-09-30

2.38

2022-06-30

1.77

2022-03-31

2.39

2021-12-31

3.58

2021-09-30

4.36

2021-06-30

4.47

2021-03-31

2.70

2020-12-31

3.07

2020-09-30

3.60

2020-06-30

4.24

2020-03-31

4.53

2019-12-31

4.95

2019-09-30

3.76

2019-06-30

4.01

2019-03-31

4.40

2018-12-31

4.86

2018-09-30

7.18

2018-06-30

6.39

2018-03-31

1.94

2017-12-31

2.21

2017-09-30

2.12

2017-06-30

2.82

2017-03-31

4.91

2016-12-31

1.60

2016-09-30

3.04

2016-06-30

2.91

2016-03-31

5.64

2015-12-31

6.83

2015-09-30

9.42

2015-06-30

10.45

2015-03-31

4.86

2014-12-31

5.41

2014-09-30

7.92

2014-06-30

9.78

2014-03-31

8.09

2013-12-31

10.43

2013-09-30

4.25

2013-06-30

3.67

2013-03-31

6.08

2012-12-31

13.02

2012-09-30

14.23

2012-06-30

4.17

2012-03-31

4.09

2011-12-31

4.94

2011-09-30

8.39

2011-06-30

6.81

2011-03-31

0.89

2010-12-31

1.60

2010-09-30

2.65

2010-06-30

2.42

2010-03-31

4.15

2009-12-31

4.41

2009-09-30

0.96

2009-06-30

1.65

2009-03-31

2.80

2008-12-31

3.39

2008-09-30

2.97

2008-06-30

4.33

2008-03-31

5.15

2007-12-31

5.77

2007-09-30

11.46

2007-06-30

12.90

2007-03-31

2.68

2006-12-31

3.87

2006-09-30

7.81

2006-06-30

9.71

2006-03-31

12.00

2005-12-31

2.77

2005-09-30

3.92

2005-06-30

4.77

2005-03-31

6.91

2004-12-31

5.42

2004-09-30

7.54

2004-06-30

10.04

2004-03-31

3.82

2003-12-31

5.95

2003-09-30

6.29

2003-06-30

6.46

2003-03-31

6.64

2002-12-31

8.01

2002-09-30

6.78

Current Ratio: 2.49

HRTX Current Ratio

HRTX Average Current Ratio Chart

HRTX Current vs Average Current Ratio Chart

HRTX Current Ratio Metrics

HRTX Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

HRTX Current Ratio History

Related Metrics